30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

David White

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 69% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Principal Accounting Officer, Vice President - Finance Five Prime Therapeutics Inc Feb. 28, 2019 - Dec. 1, 2019
Vice President - Finance Five Prime Therapeutics Inc Feb. 25, 2019 - Feb. 28, 2019
David White's trades of Fevara PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-29 2024-01-26
GB Fevara PLC (FVA)
B Purchase
61,487
131.72
£2,662,830 		61,487 131.72 £2,662,830
2023-05-19 2023-05-17
GB Fevara PLC (FVA)
B Purchase
4,275
317.83
£3,540,060 		4,275 317.83 £3,540,060